Evidence map›Paper›PMID 31268738›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.

Tianying Duan, Onur Cil, C Ming Tse, Rafiquel Sarker, Ruxian Lin, Mark Donowitz, Alan S Verkman

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Intestinal secretory mechanisms and diarrhea.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Review
  7. Chloride transport modulators as drug candidates.American journal of physiology. Cell physiology · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Tianying DuanDepartment of Medicine, University of California-San Francisco, San Francisco, California, USA.
Onur CilDepartment of Medicine, University of California-San Francisco, San Francisco, California, USA.
C Ming TseGastroenterology Division, Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Rafiquel SarkerGastroenterology Division, Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ruxian LinGastroenterology Division, Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mark DonowitzGastroenterology Division, Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alan S VerkmanDepartment of Medicine, University of California-San Francisco, San Francisco, California, USA.
Johns Hopkins Medicine · USUniversity of California, San Francisco · USSecond Xiangya Hospital of Central South University · CN

Funding

SynthesisP30DK072517 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2005 to 2022
$18.1M
Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ZACHOS, NICHOLAS CONSTANTINE · 2011 to 2020
$12.0M
Translational Approaches to Develop Drug Therapy for DiarrheaR24DK099803 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 2014 to 2019
$8.9M
Functional Role of Aquaporins in Eye PhysiologyR01EY013574 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2002 to 2022
$7.6M
Urea transport inhibitors as a new class of diureticsR01DK101373 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2014 to 2018
$1.7M
NEI NIH HHS R01 EY013574NIDDK NIH HHS P30 DK072517NIDDK NIH HHS P30 DK089502NIDDK NIH HHS R01 DK101373NIDDK NIH HHS R24 DK099803
6 · The paper itself

Abstract

Bile acid diarrhea (BAD) is common with ileal resection, Crohn's disease, and diarrhea-predominant irritable bowel syndrome. Here, we demonstrate the efficacy of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor (

Indexed as

AnimalsCell LineCells, CulturedChenodeoxycholic AcidChloridesCystic Fibrosis Transmembrane Conductance RegulatorDiarrheaFemaleHumansIntestinal MucosaIntestinal SecretionsMiceOxazinesPyrimidinonesPyrrolesRatsChenodeoxycholic AcidChloridesCystic Fibrosis Transmembrane Conductance RegulatorOxazinesPyrimidinonesPyrroles(R)-BPO-27BADCFTR inhibitorchloride channelcystic fibrosisintestinal fluid secretion

Identifiers

PMID31268738
PMCPMC6766649
OpenAlexW2955226481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.